Atreca, Inc.

Atreca, Inc.

Atreca, Inc.

Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics.
Founded
2011
Raised
$308.8M
Follow us
Alexa global traffic share
Latest funding Show all
$113,800,000
IPO - 2019
$125,000,000
Venture capital (Series C) - 2018
Redmile Group Aisling Capital EcoR1 Capital +5
Team Size
10+
Employees
$113,800,000 IPO
PE HUB

Biopharma firm Atreca goes public

$125,000,000 Venture capital (Series C)
FinSMEs , PE HUB , MedCity News

Atreca Raises $125M in Series C Funding

Funding
$35,000,000 Venture capital (Series B)
PE HUB , PE HUB

Atreca raises $35 mln Series B co-led by Wellington

Funding